EcoDrugPlus

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSCAFG00020019842
Gene Symbol: IGF1R
3 Cross references
276 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSCAFG00020023010
Gene Symbol: INSR
3 Cross references
290 Possible Orthologues:

Integrin Beta-7-Like

Ensembl ID : ENSCAFG00020021265
Gene Symbol: LOC112667269
2 Cross references
157 Possible Orthologues:

Integrin Subunit Alpha 2b

Ensembl ID : ENSCAFG00020009900
Gene Symbol: ITGA2B
3 Cross references
191 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSCAFG00020007432
Gene Symbol: ITGA4
3 Cross references
237 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSCAFG00020020389
Gene Symbol: ITGA5
3 Cross references
267 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSCAFG00020008464
Gene Symbol: ITGAV
3 Cross references
243 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSCAFG00020010708
Gene Symbol: ITGB1
3 Cross references
301 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSCAFG00020026937
Gene Symbol: ITGB3
3 Cross references
268 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSCAFG00020003635
Gene Symbol: ITGB5
3 Cross references
212 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSCAFG00020006149
Gene Symbol: ITGB6
3 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSCAFG00020021261
Gene Symbol: ITGB7
2 Cross references
157 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).